BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6302710)

  • 1. Studies in chimpanzees of live, attenuated hepatitis A vaccine candidates.
    Provost PJ; Conti PA; Giesa PA; Banker FS; Buynak EB; McAleer WJ; Hilleman MR
    Proc Soc Exp Biol Med; 1983 Mar; 172(3):357-63. PubMed ID: 6302710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward a live attenuated human hepatitis A virus vaccine.
    Hilleman MR; Provost PJ; Buynak EB; McLean AA
    Dev Biol Stand; 1983; 54():433-40. PubMed ID: 6317494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New findings in live, attenuated hepatitis A vaccine development.
    Provost PJ; Bishop RP; Gerety RJ; Hilleman MR; McAleer WJ; Scolnick EM; Stevens CE
    J Med Virol; 1986 Oct; 20(2):165-75. PubMed ID: 3021899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of prototype live hepatitis A virus vaccines in primate models.
    Karron RA; Daemer R; Ticehurst J; D'Hondt E; Popper H; Mihalik K; Phillips J; Feinstone S; Purcell RH
    J Infect Dis; 1988 Feb; 157(2):338-45. PubMed ID: 2826614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simian strain of hepatitis A virus, AGM-27, functions as an attenuated vaccine for chimpanzees.
    Emerson SU; Tsarev SA; Govindarajan S; Shapiro M; Purcell RH
    J Infect Dis; 1996 Mar; 173(3):592-7. PubMed ID: 8627022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis A virus: growth characteristics of in vivo and in vitro propagated wild and attenuated virus strains.
    Bradley DW; Schable CA; McCaustland KA; Cook EH; Murphy BL; Fields HA; Ebert JW; Wheeler C; Maynard JE
    J Med Virol; 1984; 14(4):373-86. PubMed ID: 6096505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mythology of various hepatitis A virus isolates.
    Deinhardt F; Wolfe L; Peterson D; Cross GF; Holmes AW
    Dev Biol Stand; 1975; 30():390-404. PubMed ID: 173601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live attenuated vaccine for hepatitis A.
    Feinstone SM; Daemer RJ; Gust ID; Purcell RH
    Dev Biol Stand; 1983; 54():429-32. PubMed ID: 6317493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to nonstructural proteins of hepatitis A virus following infection.
    Robertson BH; Jia XY; Tian H; Margolis HS; Summers DF; Ehrenfeld E
    J Med Virol; 1993 May; 40(1):76-82. PubMed ID: 8390561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evaluation of a live hepatitis A vaccine in marmosets.
    Provost PJ; Banker FS; Wadsworth CW; Krah DL
    J Med Virol; 1991 Aug; 34(4):227-31. PubMed ID: 1658214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
    Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
    Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental in vivo passage of H2 strain of live attenuated vaccine of hepatitis A in common marmosets].
    Huang X; Lian Y; Wang Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Sep; 31(5):260-2. PubMed ID: 9812599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine against human hepatitis B.
    Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hilleman MR
    JAMA; 1976 Jun; 235(26):2832-4. PubMed ID: 819667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible approaches to develop vaccines against hepatitis A.
    D'Hondt E
    Vaccine; 1992; 10 Suppl 1():S48-52. PubMed ID: 1335659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectivity studies of hepatitis A and B in non-human primates.
    Maynard JE; Krushak DH; Bradley DW; Berquist KR
    Dev Biol Stand; 1975; 30():229-35. PubMed ID: 173599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans.
    Mao JS; Dong DX; Zhang HY; Chen NL; Zhang XY; Huang HY; Xie RY; Zhou TJ; Wan ZJ; Wang YZ
    J Infect Dis; 1989 Apr; 159(4):621-4. PubMed ID: 2538518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers.
    Midthun K; Ellerbeck E; Gershman K; Calandra G; Krah D; McCaughtry M; Nalin D; Provost P
    J Infect Dis; 1991 Apr; 163(4):735-9. PubMed ID: 1849160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune adherence and complement-fixation tests for human hepatitis A. Diagnostic and epidemiologic investigations.
    Hilleman MR; Provost PJ; Miller WJ; Villarejos VM; Ittensohn OL; McAleer WJ
    Dev Biol Stand; 1975; 30():383-9. PubMed ID: 173600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The trial preparation of attenuated live hepatitis A vaccine].
    Dong DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):1-6. PubMed ID: 2548744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.